• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗接受减重手术的病态肥胖患者非酒精性脂肪性肝病的危险因素

The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran.

作者信息

Aghakhani Ladan, Haghighat Neda, Amini Masoud, Hosseini Seyed Vahid, Masoumi Seyed Jalil

机构信息

Student Research Committee, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran.

Laparoscopy Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Gastroenterol Res Pract. 2022 Feb 7;2022:5980390. doi: 10.1155/2022/5980390. eCollection 2022.

DOI:10.1155/2022/5980390
PMID:35178085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8845117/
Abstract

BACKGROUND AND AIMS

Nonalcoholic fatty liver disease (NAFLD) is common in severely obese individuals undergoing bariatric surgery. Assessing the prevalence and severity of NAFLD seems crucial since it may affect the prevention or development of more severe forms of fatty liver.

METHODS

This cross-sectional study was conducted on 228 severely obese individuals undergoing bariatric surgery. Abdominal ultrasonography was done, and clinical and biochemical factors (liver enzymes, lipid profile, and fasting blood sugar (FBS)) were assessed.

RESULTS

The mean body mass index (BMI) was 43.45 ± 5.92 kg/m. The prevalence of NAFLD was 49.12% (mild steatosis: 37.5%, moderate steatosis: 36.6%, and severe steatosis: 25.8%). The main risk factors of NAFLD were weight ( = 0.002), BMI ( = 0.003), alanine aminotransferase (ALT) ( < 0.001), aspartate aminotransferase (AST) ( < 0.001), serum triglycerides (TGs) ( = 0.004), and FBS ( = 0.039). The results revealed a statistically significant decrease in the mean level of high-density lipoprotein cholesterol (HDL-C) ( = 0.044). However, no significant association was found between the severity of liver steatosis and the presence of comorbidities such as hypertension, diabetes, hypothyroidism, and dyslipidemia.

CONCLUSIONS

More severe NAFLD was associated with increased weight and BMI. Elevated ALT, AST, TG, and FBS levels and decreased HDL-C levels were also the risk factors of NAFLD and its progress to more severe conditions.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)在接受减肥手术的严重肥胖个体中很常见。评估NAFLD的患病率和严重程度似乎至关重要,因为它可能影响更严重形式脂肪肝的预防或发展。

方法

本横断面研究对228例接受减肥手术的严重肥胖个体进行。进行腹部超声检查,并评估临床和生化因素(肝酶、血脂谱和空腹血糖(FBS))。

结果

平均体重指数(BMI)为43.45±5.92kg/m。NAFLD的患病率为49.12%(轻度脂肪变性:37.5%,中度脂肪变性:36.6%,重度脂肪变性:25.8%)。NAFLD的主要危险因素为体重(=0.002)、BMI(=0.003)、丙氨酸氨基转移酶(ALT)(<0.001)、天冬氨酸氨基转移酶(AST)(<0.001)、血清甘油三酯(TGs)(=0.004)和FBS(=0.039)。结果显示高密度脂蛋白胆固醇(HDL-C)平均水平有统计学显著下降(=0.044)。然而,未发现肝脂肪变性严重程度与高血压、糖尿病、甲状腺功能减退和血脂异常等合并症之间存在显著关联。

结论

更严重的NAFLD与体重和BMI增加有关。ALT、AST、TG和FBS水平升高以及HDL-C水平降低也是NAFLD及其进展为更严重情况的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4899/8845117/0da618988dcc/GRP2022-5980390.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4899/8845117/0da618988dcc/GRP2022-5980390.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4899/8845117/0da618988dcc/GRP2022-5980390.001.jpg

相似文献

1
The Risk Factors of Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients Undergoing Bariatric Surgery in Iran.伊朗接受减重手术的病态肥胖患者非酒精性脂肪性肝病的危险因素
Gastroenterol Res Pract. 2022 Feb 7;2022:5980390. doi: 10.1155/2022/5980390. eCollection 2022.
2
Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.年龄在 45-60 岁的中国人群中,非酒精性脂肪肝与高血压之间的相关性存在性别差异。
Clin Exp Hypertens. 2016;38(7):639-643. doi: 10.1080/10641963.2016.1182181. Epub 2016 Sep 28.
3
The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.非酒精性脂肪性肝病患者非酒精性脂肪性肝病纤维化评分、脂肪变性严重程度与 FIB-4 指数与动脉粥样硬化性血脂异常的关系:一项横断面研究。
Int J Clin Pract. 2021 Jun;75(6):e14131. doi: 10.1111/ijcp.14131. Epub 2021 Mar 21.
4
Improvement of nonalcoholic fatty liver disease in morbidly obese patients after sleeve gastrectomy: association of ultrasonographic findings with lipid profile and liver enzymes.袖状胃切除术后病态肥胖患者非酒精性脂肪性肝病的改善:超声检查结果与血脂和肝酶的关联
Acta Chir Belg. 2017 Dec;117(6):363-369. doi: 10.1080/00015458.2017.1334858. Epub 2017 Jun 6.
5
Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术患者脂肪肝疾病分级与围手术期危险因素的比较
Cureus. 2024 Sep 19;16(9):e69717. doi: 10.7759/cureus.69717. eCollection 2024 Sep.
6
Biochemical markers and lipid profile in nonalcoholic fatty liver disease patients in the PERSIAN Guilan cohort study (PGCS), Iran.伊朗PERSIAN吉兰队列研究(PGCS)中非酒精性脂肪性肝病患者的生化标志物和血脂谱
J Family Med Prim Care. 2019 Mar;8(3):923-928. doi: 10.4103/jfmpc.jfmpc_243_18.
7
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.肥胖和代谢综合征作为通过超声诊断的非酒精性脂肪性肝病发生的风险因素。
Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P.
8
Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients.菲律宾健康人群中超声检查非酒精性脂肪性肝病严重程度与心脏代谢风险的相关性
J Cardiovasc Thorac Res. 2017;9(2):85-89. doi: 10.15171/jcvtr.2017.14. Epub 2017 Jun 8.
9
Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.青少年残余脂蛋白胆固醇水平与非酒精性脂肪性肝病之间的关联
JHEP Rep. 2020 Jul 24;2(6):100150. doi: 10.1016/j.jhepr.2020.100150. eCollection 2020 Dec.
10
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.意大利南部严重肥胖的非糖尿病青年成人中的非酒精性脂肪性肝病
Ann Nutr Metab. 2005 Sep-Oct;49(5):289-95. doi: 10.1159/000087295. Epub 2005 Aug 2.

引用本文的文献

1
Analysis and study of risk factors related to the progression of non-alcoholic fatty liver disease: A retrospective cohort study.非酒精性脂肪性肝病进展相关危险因素的分析与研究:一项回顾性队列研究。
PLoS One. 2025 May 7;20(5):e0322990. doi: 10.1371/journal.pone.0322990. eCollection 2025.
2
A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease.一项随机双盲临床试验,旨在研究鞣花酸对非酒精性脂肪性肝病患者血糖状况、肝酶和氧化应激的影响。
BMC Complement Med Ther. 2025 Jan 30;25(1):33. doi: 10.1186/s12906-025-04759-4.
3

本文引用的文献

1
Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.甘油三酯介导体重指数与非酒精性脂肪性肝病的关系:一项基于人群的研究。
Obes Facts. 2021;14(2):190-196. doi: 10.1159/000514848. Epub 2021 Mar 29.
2
The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women - A Cross-sectional Study from Southern India.病态肥胖女性非酒精性脂肪性肝病的患病率及预测因素——一项来自印度南部的横断面研究
Eur Endocrinol. 2020 Oct;16(2):152-155. doi: 10.17925/EE.2020.16.2.152. Epub 2020 Oct 6.
3
Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme.
Comparison of the Grades of Fatty Liver Disease With Perioperative Risk Factors in Patients With Laparoscopic Sleeve Gastrectomy.
腹腔镜袖状胃切除术患者脂肪肝疾病分级与围手术期危险因素的比较
Cureus. 2024 Sep 19;16(9):e69717. doi: 10.7759/cureus.69717. eCollection 2024 Sep.
4
Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals.非酒精性脂肪性肝病相关危险因素分析:一项基于31718名中国成年个体的回顾性研究。
Front Med (Lausanne). 2023 Jun 29;10:1168499. doi: 10.3389/fmed.2023.1168499. eCollection 2023.
在以牛奶为基础的代餐计划期间,重度和复杂肥胖成人丙氨酸转氨酶的变化。
Nutr Metab (Lond). 2020 Oct 16;17:87. doi: 10.1186/s12986-020-00512-5. eCollection 2020.
4
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病(NAFLD)在 1 型糖尿病患者中的流行情况:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3842-53. doi: 10.1210/clinem/dgaa575.
5
Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons.非酒精性脂肪性肝病的治疗及减重手术的作用:外科医生的简要综述。
Surg Obes Relat Dis. 2020 May;16(5):699-703. doi: 10.1016/j.soard.2020.01.028. Epub 2020 Feb 5.
6
Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran.糖尿病、高脂血症、肥胖症和多囊卵巢综合征患者中非酒精性脂肪性肝病的患病率:伊朗北部的一项横断面研究。
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1591-1596. doi: 10.1016/j.dsx.2019.03.009. Epub 2019 Mar 8.
7
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.肥胖与非酒精性脂肪性肝病:从病理生理学到治疗学。
Metabolism. 2019 Mar;92:82-97. doi: 10.1016/j.metabol.2018.11.014. Epub 2018 Nov 29.
8
Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病
Prim Care. 2017 Dec;44(4):599-607. doi: 10.1016/j.pop.2017.07.003.
9
Non-alcohol fatty liver disease in Asia: Prevention and planning.亚洲的非酒精性脂肪性肝病:预防与规划
World J Hepatol. 2015 Jul 8;7(13):1788-96. doi: 10.4254/wjh.v7.i13.1788.
10
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.接受减肥手术的青少年中非酒精性脂肪性肝病的高患病率。
Gastroenterology. 2015 Sep;149(3):623-34.e8. doi: 10.1053/j.gastro.2015.05.039. Epub 2015 May 28.